Source: FinanzNachrichten

Hain Lifescience: Hain Lifescience: Rapid, Comprehensive Diagnosis of MDR-TB

NEHREN, Germany, April 25, 2017 /PRNewswire/ -- Increasing antibiotic resistance requires rapid and comprehensive diagnosis. The new PCR-based FluoroType MTBDR test identifies tuberculosis (TB) pa...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
CEO Avatar

General Manager

David Hain

CEO Approval Rating

80/100

Read more